首页 工具
登录
购物车
Varenicline Tartrate

Varenicline Tartrate

产品编号 T1657   CAS 375815-87-5
别名: Champix tartrate, 酒石酸伐尼克兰, Chantix tartrate, CP 526555-18, 酒石酸伐仑克林

Varenicline Tartrate (CP 526555-18) 是α4β2 烟碱乙酰胆碱受体的部分激动剂,EC50为 2.3 μM。它是 α3β4 和 α7 乙酰胆碱受体完全激动剂,EC50值分别为 55 和 18 μM,用于戒烟方面的研究。

TargetMol的所有产品和服务仅用于科学研究,不能被用于人体,我们也不向个人提供产品和服务。
Varenicline Tartrate Chemical Structure
Varenicline Tartrate, CAS 375815-87-5
规格 价格/CNY 货期 数量
1 mg ¥ 266 现货
2 mg ¥ 378 现货
5 mg ¥ 616 现货
10 mg ¥ 955 现货
25 mg ¥ 1,660 现货
50 mg ¥ 2,890 现货
100 mg ¥ 4,330 现货
500 mg ¥ 9,350 现货
1 mL * 10 mM (in DMSO) ¥ 671 现货
其他形式的 Varenicline Tartrate:
千万补贴 助力科研
BCA蛋白浓度测定试剂盒限时半价
产品目录号及名称: Varenicline Tartrate (T1657)
点击图片重新获取验证码
选择批次  
纯度: 99.9%
纯度: 98%
TargetMol batch loading
更多批次查询请联系客服
生物活性
化学信息
存储 & 溶解度
参考文献
产品描述 Varenicline Tartrate (CP 526555-18) is a benzazepine derivative that functions as an ALPHA4/BETA2 NICOTINIC RECEPTOR partial agonist. It is used for SMOKING CESSATION.
体外活性 Varenicline is a partial agonist with 45% of nicotine's maximal efficacy atalpha4beta2 nAChRs in HEK cells expressing nAChRs. [1] Varenicline is a potent, partial agonist at alpha4beta2 receptors, with an EC50 of 2.3 mM and an efficacy (relative to acetylcholine) of 13.4%. Varenicline has lower potency and higher efficacy at alpha3beta4 receptors, with an EC50 of 55 mM and an efficacy of 75%. [2]
体内活性 Varenicline has significantly lower (40-60%) efficacy than nicotine in stimulating [(3)H]-dopamine release from rat brain slices in vitro and in increasing dopamine release from rat nucleus accumbens in vivo, while it is more potent than Nicotine. Varenicline effectively attenuates the nicotine-induced dopamine release to the level of the effect of Varenicline alone, consistent with partial agonism. Varenicline reduces nicotine self-administration in rats and supports lower self-administration break points than nicotine. [1] Varenicline dose-dependently reduces nicotine self-administration and attenuates both nicotine prime and combined nicotine prime plus nicotine-paired cue-induced reinstatement. [3] Varenicline, a partial agonist at thealpha4beta2 nAChRs, reduces nicotine intake and was recently approved as a smoking cessation aid. Varenicline selectively reduces ethanol but not sucrose seeking using an operant self-administration drinking paradigm and also decreases voluntary ethanol but not water consumption in animals chronically exposed to ethanol for 2 months before Varenicline treatment. [4]
激酶实验 Kinase inhibition: Vandetanib is incubated with enzyme, 10 mM MnCl2, and 2 μM ATP in 96-well plates coated with a poly(Glu, Ala, Tyr) 6:3:1 random copolymer substrate. Phosphorylated tyrosine is then detected by sequential incubation with a mouse IgG anti-phosphotyrosine 4 g10 antibody, a horseradish peroxidase-linked sheep antimouse immunoglobulin antibody, and 2,2′-azino-bis(3-ethylbenzthiazoline-6-sulfonic acid). This methodology is adapted to examine selectivity versus tyrosine kinases associated with EGFR, PDGFRβ, Tie-2, FGFR1, c-kit, erbB2, IGF-1R, and FAK. All enzyme assays (tyrosine or serine-threonine) used appropriate ATP concentrations at or just below the respective Km (0.2–14 μM). Selectivity versus serine-threonine kinases (CDK2, AKT, and PDK1) is examined using a relevant scintillation proximity-assay (SPA) in 96-well plates. CDK2 assays contained 10 mM MnCl2, 4.5 μM ATP, 0.15 μCi of [γ-33 P]ATP/reaction, 50 mM HEPES (pH 7.5), 1 mM DTT, 0.1 mM sodium orthovanadate, 0.1 mM sodium fluoride, 10 mM sodium glycerophosphate, 1 mg/mL BSA fraction V, and a retinoblastoma substrate (part of the retinoblastoma gene, 792–928, expressed in a glutathione S-transferase expression system; 0.22 μM final concentration). Reactions are allowed to proceed at room temperature for 60 minutes before quenching for 2 hours with 150 μL of a solution containing EDTA (62 mM final concentration), 3 μg of a rabbit immunoglobulin anti-glutathione S-transferase antibody and protein A SPA-polyvinyltoluene beads (0.8 mg/reaction). Plates are then sealed, centrifuged (1200× g for 5 minutes), and counted on a Microplate scintillation counter for 30 seconds.
别名 Champix tartrate, 酒石酸伐尼克兰, Chantix tartrate, CP 526555-18, 酒石酸伐仑克林
分子量 361.35
分子式 C13H13N3·C4H6O6
CAS No. 375815-87-5

存储

Powder: -20°C for 3 years | In solvent: -80°C for 1 year

溶解度

DMSO: 3.61 mg/mL (10 mM)

溶液配制表

可选溶剂 浓度 体积 质量 1 mg 5 mg 10 mg 25 mg
DMSO 1 mM 2.7674 mL 13.837 mL 27.674 mL 69.185 mL
5 mM 0.5535 mL 2.7674 mL 5.5348 mL 13.837 mL
10 mM 0.2767 mL 1.3837 mL 2.7674 mL 6.9185 mL

TargetMol Calculator计算器

摩尔浓度计算器
稀释计算器
配液计算器
分子量计算器
=
X
X
X
=
X
=
/
g/mol

输入分子式,点击计算,可计算出产品的分子量。

TargetMol Library Books参考文献

1. Rollema H, et al. Neuropharmacology, 2007, 52(3), 1985-1994. 2. Mihalak KB, et al. Mol Pharmacol, 2006, 70(3), 801-805. 3. O'Connor EC, et al. Psychopharmacology (Berl), 2010, 208(3), 365-376. 4. Steensland P, et al. Proc Natl Acad Sci U S A, 2007, 104(30), 12518-12523.
Benzethonium chloride Carbaryl SEN12333 SIB-1553A hydrochloride Ipratropium Bromide Epiberberine (-)-OPC-51803 Choline bitartrate

相关化合物库

该产品包含在如下化合物库中:
膜蛋白靶向化合物库 神经退行性疾病化合物库 药物功能重定位化合物库 EMA 上市药物库 神经信号分子库 抗阿尔茨海默症化合物库 神经递质受体化合物库 FDA 上市药物库 NO PAINS 化合物库 经典已知活性库

TargetMol Calculator剂量换算

对于不同动物的给药剂量换算,您也可以参考 更多...

TargetMol Calculator 体内实验配液计算器

请在以下方框中输入您的动物实验信息后点击计算,可以得到母液配置方法和体内配方的制备方法: 比如您的给药剂量是10 mg/kg,每只动物体重20 g,给药体积100 μL,一共给药动物10 只,您使用的配方为5% DMSO+30% PEG300+5% Tween 80+60% ddH2O。那么您的工作液浓度为2 mg/mL。

母液配置方法:2 mg 药物溶于 50 μL DMSO (母液浓度为 40 mg/mL), 如您需要配置的浓度超过该产品的溶解度,请先与我们联系。

体内配方的制备方法:取 50 μL DMSO 主液,加入 300 μL PEG300, 混匀澄清,再加 50 μL Tween 80,混匀澄清,再加 600 μL ddH2O, 混匀澄清。

第一步:请输入动物实验的基本信息
剂量
mg/kg
每只动物体重
g
给药体积
μL
动物数量
第二步:请输入动物体内配方组成,不同的产品配方组成不同,如有配方需求,可先联系我们提供正确的体内配方。
% DMSO
%
% Tween 80
% ddH2O
计算 重置

技术支持

您可能有的问题的答案可以在抑制剂处理说明中找到,包括如何准备库存溶液,如何存储产品,以及基于细胞的分析和动物实验需要特别注意的问题。

Keywords

Varenicline Tartrate 375815-87-5 Neuroscience AChR Nicotinic acetylcholine receptors Champix tartrate 酒石酸伐尼克兰 Inhibitor Champix Tartrate Varenicline inhibit Chantix tartrate Chantix Tartrate nAChR CP 526555-18 酒石酸伐仑克林 inhibitor

 

TargetMol Loading
陶术
生物
TargetMol®中国区唯一合作伙伴
点击进入陶术生物官网陶术生物
联系我们
400-820-0310

上海市静安区江场三路238号8楼